Source: Annual Congress 2007 - Complications and success in lung transplantation
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
P. Morales, J. A. Ros, M. Blanes, V. Saiz, D. Pérez-Enguix, M. Santos (Valencia, Murcia, Spain). Mycobacterium abscessus infection in lung transplant patients: review of our series. Eur Respir J 2007; 30: Suppl. 51, 1105

Member's Comments

No comment yet.

Related content which might interest you: Mycobacterium abscessus respiratory infection: importance in immunosuppressed patients Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous Year: 2008 Impact of isolation of mycobacterium abscessus on lung transplantation in CF patients Source: Eur Respir J 2001; 18: Suppl. 33, 126s Year: 2001 Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis Source: Eur Respir J, 54 (1) 1801991; 10.1183/13993003.01991-2018 Year: 2019 Paediatric lung transplant outcomes vary with Mycobacterium abscessus complex species Source: Eur Respir J 2013; 41: 1230-1232 Year: 2013 LATE-BREAKING ABSTRACT: Poor outcome following lung transplantation in CF patients infected with mycobacterium abscessus appears to be associated with two genetic clusters of mycobacterium abscessus subspecies abscessus Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016 A patient with cystic fibrosis and Mycobacterium abscessus infection Source: International Congress 2018 – CC1 Lung transplantation Year: 2018 Lung function evolution in patients with microbiological isolation of Mycobacterium abscessus Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection Year: 2019 Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment Source: Eur Respir J 2003; 21: 478-482 Year: 2003 Pneumonectomy in lung infections with Mycobacterium tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 459s Year: 2001 Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systemic review and meta-analysis Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019 Treatment of human disease due to Mycobacterium bovis: a systematic review Source: Eur Respir J 2016; 48: 1500-1503 Year: 2016 Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients Source: Eur Respir J 2013; 41: 1101-1106 Year: 2013 Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease Source: Eur Respir J 2009; 33: 148-152 Year: 2009 Mycobacterium tuberculosis transmission from patients with drug-resistant compared to drug-susceptible TB: a systematic review and meta-analysis Source: Eur Respir J, 50 (4) 1701044; 10.1183/13993003.01044-2017 Year: 2017 Isolation of M. abscessus from patients with M. avium complex (MAC) lung disease Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013 Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease Source: Eur Respir J 2005; 26: 1092-1096 Year: 2005 Lung transplantation: Mycobacterium abscessus as a cause of graft dysfunction Source: ISSN=ISSN 1810-6838, ISBN=, page=291 Year: 2007 Mycobacterium chelonae-induced mycobacteriosis of the lungs: a case report Source: Eur Respir J 2002; 20: Suppl. 38, 553s Year: 2002